| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP Finance CFO | SVP Finance &CFO
2 companies
Landry Robert E is an EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 58 sells.
Estimated insider holdings value: $15.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 383 | $678.95 | $260,038.00 | -0.7% | -18.1% | +9.1% | |
| Dec 13, 2021 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 116 | $662.50 | $76,850.00 | -0.4% | -0.6% | +13.2% | |
| Dec 10, 2021 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 781 | $666.42 | $520,477.26 | -0.2% | -5.8% | +12.0% | |
| Nov 17, 2021 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 681 | $645.08 | $439,299.48 | -2.6% | -1.8% | +15.2% | |
| Aug 10, 2021 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 901 | $614.30 | $553,483.56 | -0.2% | +1.3% | +4.3% | |
| Aug 4, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sell | 696 | $654.46 | $455,504.16 | -2.8% | - | - | |
| Jul 21, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 391 | $647.58 | $253,204.00 | -0.8% | - | - | |
| Jul 14, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sell | 579 | $640.50 | $370,849.50 | -2.4% | - | - | |
| Jul 8, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 1,160 | $639.66 | $742,010.65 | -0.4% | - | - | |
| Jun 29, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sell | 400 | $612.57 | $245,028.72 | -0.3% | - | - |